What is the role of bosentan in healing of femur fractures in a rat model?
详细信息    查看全文
  • 作者:Ali Aydin ; Zekai Halici ; Erol Akpinar…
  • 关键词:Bosentan ; Endothelin聽1 ; Bone fracture ; Rat ; Femur
  • 刊名:Journal of Bone and Mineral Metabolism
  • 出版年:2015
  • 出版时间:September 2015
  • 年:2015
  • 卷:33
  • 期:5
  • 页码:496-506
  • 全文大小:1,740 KB
  • 参考文献:1.Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y et al (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411鈥?15CrossRef PubMed
    2.Piechota A, Polanczyk A, Goraca A (2010) Role of endothelin-1 receptor blockers on hemodynamic parameters and oxidative stress. Pharmacol Rep 62:28鈥?4CrossRef PubMed
    3.Resink TJ, Scott-Burden T, Buhler FR (1990) Activation of multiple signal transduction pathways by endothelin in cultured human vascular smooth muscle cells. Eur J Biochem 189:415鈥?21CrossRef PubMed
    4.Suzuki T, Kumazaki T, Mitsui Y (1993) Endothelin-1 Is produced and secreted by neonatal rat cardiac myocytes in vitro. Biochem Biophys Res Commun 191:823鈥?30CrossRef PubMed
    5.Ehrenreich H, Anderson RW, Fox CH, Rieckmann P, Hoffman GS, Travis WD et al (1990) Endothelins, peptides with potent vasoactive properties, are produced by human macrophages. J Exp Med 172:1741鈥?748CrossRef PubMed
    6.Giaid A, Gibson SJ, Ibrahim NBN, Legon S, Bloom SR, Yanagisawa M et al (1989) Endothelin-1, an endothelium-derived peptide, is expressed in neurons of the human spinal-cord and dorsal-root ganglia. Proc Natl Acad Sci USA 86:7634鈥?638PubMed Central CrossRef PubMed
    7.Nelson J, Bagnato A, Battistini B, Nisen P (2003) The endothelin axis: emerging role in cancer. Nat Rev Cancer 3:110鈥?16CrossRef PubMed
    8.Mestek ML, Weil BR, Greiner JJ, Westby CM, DeSouza CA, Stauffer BL (2010) Osteopenia and endothelin-1-mediated vasconstrictor tone in postmenopausal women. Bone 47:542鈥?45PubMed Central CrossRef PubMed
    9.Gulhan I, Kebapcilar L, Alacacioglu A, Bilgili S, Kume T, Aytac B et al (2009) Postmenopausal women with osteoporosis may be associated with high endothelin-1. Gynecol Endocrinol 25:674鈥?78CrossRef PubMed
    10.Chang JM, Kuo MC, Chen HM, Lee CH, Lai YH, Chen HC et al (2006) Endothelin-1 regulates parathyroid hormone expression of human parathyroid cells. Clin Nephrol 66:25鈥?1CrossRef PubMed
    11.Tatrai A, Foster S, Lakatos P, Shankar G, Stern PH (1992) Endothelin-1 actions on resorption, collagen and noncollagen protein synthesis, and phosphatidylinositol turnover in bone organ cultures. Endocrinology 131:603鈥?07PubMed
    12.von Schroeder HP, Veillette CJ, Payandeh J, Qureshi A, Heersche JN (2003) Endothelin-1 promotes osteoprogenitor proliferation and differentiation in fetal rat calvarial cell cultures. Bone 33:673鈥?84CrossRef
    13.Zhong X, Wang H, Huang S (2014) Endothelin-1 induces interleukin-18 expression in human osteoblasts. Arch Oral Biol 59:289鈥?96CrossRef PubMed
    14.Stern PH, Tatrai A, Semler DE, Lee SK, Lakatos P, Strieleman PJ et al (1995) Endothelin receptors, second messengers, and actions in bone. J Nutr 125:2028S鈥?032SPubMed
    15.MacKenzie EJ, Bosse MJ, Pollak AN, Webb LX, Swiontkowski MF, Kellam JF et al (2005) Long-term persistence of disability following severe lower-limb trauma. Results of a seven-year follow-up. J Bone Joint Surg Am 87:1801鈥?809CrossRef PubMed
    16.Stauffer BL, Hoetzer GL, Smith DT, DeSouza CA (2004) Plasma C-reactive protein is not elevated in physically active postmenopausal women taking hormone replacement therapy. J Appl Physiol 96:143鈥?48CrossRef PubMed
    17.Cardillo C, Campia U, Bryant MB, Panza JA (2002) Increased activity of endogenous endothelin in patients with type II diabetes mellitus. Circulation 106:1783鈥?787CrossRef PubMed
    18.Trueta J, Buhr AJ (1963) The vascular contribution to osteogenesis V. The vasculature supplying the epiphysial cartilage in rachitic rats. J Bone Joint Surg Br 45:572鈥?81PubMed
    19.Trueta J, Little K (1960) The vascular contribution to osteogenesis. II. Studies with the electron microscope. J Bone Joint Surg Br 42-B:367鈥?76PubMed
    20.Hauge EM, Qvesel D, Eriksen EF, Mosekilde L, Melsen F (2001) Cancellous bone remodeling occurs in specialized compartments lined by cells expressing osteoblastic markers. J Bone Miner Res 16:1575鈥?582CrossRef PubMed
    21.Clarkin CE, Gerstenfeld LC (2013) VEGF and bone cell signalling: an essential vessel for communication? Cell Biochem Funct 31:1鈥?1CrossRef PubMed
    22.Maes C, Kobayashi T, Selig MK, Torrekens S, Roth SI, Mackem S et al (2010) Osteoblast precursors, but not mature osteoblasts, move into developing and fractured bones along with invading blood vessels. Dev Cell 19:329鈥?44PubMed Central CrossRef PubMed
    23.Tsiridis E, Upadhyay N, Giannoudis P (2007) Molecular aspects of fracture healing: which are the important molecules? Injury 38:S11鈥?5CrossRef PubMed
    24.Rath B, Nam J, Knobloch TJ, Lannutti JJ, Agarwal S (2008) Compressive forces induce osteogenic gene expression in calvarial osteoblasts. J Biomech 41:1095鈥?103PubMed Central CrossRef PubMed
    25.Dickson KF, Katzman S, Paiement G (1995) The importance of the blood supply in the healing of tibial fractures. Contemp Orthop 30:489鈥?93PubMed
    26.Park S, Han SH, Lee TJ (1999) Algorithm for recipient vessel selection in free tissue transfer to the lower extremity. Plast Reconstr Surg 103:1937鈥?948CrossRef PubMed
    27.Lu C, Miclau T, Hu D, Marcucio RS (2007) Ischemia leads to delayed union during fracture healing: a mouse model. J Orthop Res 25:51鈥?1PubMed Central CrossRef PubMed
    28.Lu C, Hansen E, Sapozhnikova A, Hu D, Miclau T, Marcucio RS (2008) Effect of age on vascularization during fracture repair. J Orthop Res 26:1384鈥?389PubMed Central CrossRef PubMed
    29.Teplyakov AI (2004) Endothelin-1 involved in systemic cytokine network inflammatory response at atherosclerosis. J Cardiovasc Pharmacol 44:S274鈥?75CrossRef PubMed
    30.Skalska AB, Pietrzycka A, Stepniewski M (2009) Correlation of endothelin 1 plasma levels with plasma antioxidant capacity in elderly patients treated for hypertension. Clin Biochem 42:358鈥?64CrossRef PubMed
    31.Li L, Watts SW, Banes AK, Galligan JJ, Fink GD, Chen AF (2003) NADPH oxidase-derived superoxide augments endothelin-1-induced venoconstriction in mineralocorticoid hypertension. Hypertension 42:316鈥?21CrossRef PubMed
    32.Onuoha GN, Alpar EK (2000) Elevation of plasma CGRP and SP levels in orthopedic patients with fracture neck of femur. Neuropeptides 34:116鈥?20CrossRef PubMed
    33.Shuid AN, Mohamad S, Muhammad N, Fadzilah FM, Mokhtar SA, Mohamed N et al (2011) Effects of alpha-tocopherol on the early phase of osteoporotic fracture healing. J Orthop Res 29:1732鈥?738CrossRef PubMed
    34.Kim SH, Kim JH, You DG, Saravanakumar G, Yoon HY, Choi KY et al (2013) Self-assembled dextran sulphate nanoparticles for targeting rheumatoid arthritis. Chem Commun 49:10349鈥?0351CrossRef
    35.Huo MH, Troiano NW, Pelker RR, Gundberg CM, Friedlaender GE (1991) The influence of ibuprofen on fracture repair: biomechanical, biochemical, histologic, and histomorphometric parameters in rats. J Orthop Res 9:383鈥?90CrossRef PubMed
    36.Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2-螖螖CT method. Methods 25:402鈥?08CrossRef PubMed
    37.Cho TJ, Kim JA, Chung CY, Yoo WJ, Gerstenfeld LC, Einhorn TA et al (2007) Expression and role of interleukin-6 in distraction osteogenesis. Calcif Tissue Int 80:192鈥?00CrossRef PubMed
    38.Kon T, Cho TJ, Aizawa T, Yamazaki M, Nooh N, Graves D et al (2001) Expression of osteoprotegerin, receptor activator of NF-魏B ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing. J Bone Miner Res 16:1004鈥?014CrossRef PubMed
    39.Pan WTET (1992) The biochemistry of fracture healing. Curr Orthop 6:207213CrossRef
    40.Dinarello CA, Mier JW (1987) Lymphokines. N Engl J Med 317:940鈥?45CrossRef PubMed
    41.Kimble RB, Vannice JL, Bloedow DC, Thompson RC, Hopfer W, Kung VT et al (1994) Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats. J Clin Invest 93:1959鈥?967PubMed Central CrossRef PubMed
    42.Kimble RB, Bain S, Pacifici R (1997) The functional block of TNF but not of IL-6 prevents bone loss in ovariectomized mice. J Bone Miner Res 12:935鈥?41CrossRef PubMed
    43.Skj酶dt H, Russell G (1992) Bone cell biology and the regulation of bone turnover. In: Gowen M (ed) Cytokines and Bone Metabolism. CRC, Boca Raton
    44.Stashenko P, Dewhirst FE, Peros WJ, Kent RL, Ago JM (1987) Synergistic interactions between interleukin-1, tumor-necrosis-factor, and lymphotoxin in bone-resorption. J Immunol 138:1464鈥?468PubMed
    45.Skalska AB, Pietrzycka A, Stepniewski M (2009) Correlation of endothelin 1 plasma levels with plasma antioxidant capacity in elderly patients treated for hypertension. Clin Biochem 42:358鈥?64CrossRef PubMed
    46.Teplyakov AI (2004) Endothelin-1 involved in systemic cytokine network inflammatory response at atherosclerosis. J Cardiovasc Pharmacol 44:S274鈥揝275CrossRef PubMed
    47.Ruetten H, Thiemermann C (1997) Endothelin-1 stimulates the biosynthesis of tumour necrosis factor in macrophages: ET-receptors, signal transduction and inhibition by dexamethasone. J Physiol Pharmacol 48:675鈥?88PubMed
    48.Yang TL, Chen MF, Jiang JL, Xie QY, Li YP, Li YJ (2005) The endothelin receptor antagonist decreases is chemia/reperfusion-induced tumor necrosis factor production in isolated rat hearts. Int J Cardiol 100:495鈥?98CrossRef PubMed
    49.Riad A, Bien S, Gratz M, Escher F, Westermann D, Heimesaat MM et al (2008) Toll-like receptor-4 deficiency attenuates doxorubicin-induced cardiomyopathy in mice. Eur J Heart Fail 10:233鈥?43CrossRef PubMed
    50.Yayla M, Halici Z, Unal B, Bayir Y, Akpinar E, Gocer F (2014) Protective effect of Et-1 receptor antagonist bosentan on paracetamol induced acute liver toxicity in rats. Eur J Pharmacol 726:87鈥?5
    51.Lu CY, Miclau T, Hu D, Marcucio RS (2007) Ischemia leads to delayed union during fracture healing: a mouse model. J Orthop Res 25:51鈥?1PubMed Central CrossRef PubMed
    52.Patel JN, Jager A, Schalkwijk C, Corder R, Douthwaite JA, Yudkin JS et al (2002) Effects of tumour necrosis factor-alpha in the human forearm: blood flow and endothelin-1 release. Clin Sci (Lond) 103:409鈥?15CrossRef
    53.Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N (1999) VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 5:623鈥?28CrossRef PubMed
    54.Huh JE, Kwon NH, Baek YH, Lee JD, Choi DY, Jingushi S et al (2009) Formononetin promotes early fracture healing through stimulating angiogenesis by up-regulating VEGFR-2/Flk-1 in a rat fracture model. Int Immunopharmacol 9:1357鈥?365CrossRef PubMed
    55.Kandalaft LE, Motz GT, Busch J, Coukos G (2011) Angiogenesis and the tumor vasculature as antitumor immune modulators: the role of vascular endothelial growth factor and endothelin. Cancer Immunol Immunother 344:129鈥?48CrossRef
    56.Grimshaw MJ (2005) Endothelins in breast tumour cell invasion. Cancer Lett 222:129鈥?38CrossRef PubMed
    57.Antonarakis ES, Carducci MA, Eisenberger MA (2010) Novel targeted therapeutics for metastatic castration-resistant prostate cancer. Cancer Lett 291:1鈥?3PubMed Central CrossRef PubMed
    58.Aldridge SE, Lennard TW, Williams JR, Birch MA (2005) Vascular endothelial growth factor receptors in osteoclast differentiation and function. Biochem Biophys Res Commun 335:793鈥?98CrossRef PubMed
    59.Sipola A, Nelo K, Hautala T, Ilvesaro J, Tuukkanen J (2006) Endostatin inhibits VEGF-A induced osteoclastic bone resorption in vitro. BMC Musculoskelet Disord 7:56PubMed Central CrossRef PubMed
    60.Kayal RA, Tsatsas D, Bauer MA, Allen B, Al-Sebaei MO, Kakar S et al (2007) Diminished bone formation during diabetic fracture healing is related to the premature resorption of cartilage associated with increased osteoclast activity. J Bone Miner Res 22:560鈥?68PubMed Central CrossRef PubMed
    61.James ND, Caty A, Borre M, Zonnenberg BA, Beuzeboc P, Morris T et al (2009) Safety and efficacy of the specific endothelin-A receptor antagonist ZD4054 in patients with hormone-resistant prostate cancer and bone metastases who were pain free or mildly symptomatic: a double-blind, placebo-controlled, randomised, phase 2 trial. Eur Urol 55:1112鈥?123CrossRef PubMed
    62.James ND, Caty A, Payne H, Borre M, Zonnenberg BA, Beuzeboc P et al (2010) Final safety and efficacy analysis of the specific endothelin A receptor antagonist zibotentan (ZD4054) in patients with metastatic castration-resistant prostate cancer and bone metastases who were pain-free or mildly symptomatic for pain: a double-blind, placebo-controlled, randomized phase II trial. BJU Int 106:966鈥?73CrossRef PubMed
    63.Grimshaw MJ (2007) Endothelins and hypoxia-inducible factor in cancer. Endocr Relat Cancer 14:233鈥?44CrossRef PubMed
    64.Guise TA, Mohammad KS (2004) Endothelins in bone cancer metastases. Cancer Treat Res 118:197鈥?12CrossRef PubMed
    65.Ingram RT, Clarke BL, Fisher LW, Fitzpatrick LA (1993) Distribution of noncollagenous proteins in the matrix of adult human bone: evidence of anatomic and functional heterogeneity. J Bone Miner Res 8:1019鈥?029CrossRef PubMed
    66.Hauschka PV, Lian JB, Cole DE, Gundberg CM (1989) Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol Rev 69:990鈥?047PubMed
    67.Goldstone AP, Howard JK, Lord GM, Ghatei MA, Gardiner JV, Wang ZL et al (2002) Leptin prevents the fall in plasma osteocalcin during starvation in male mice. Biochem Biophys Res Commun 295:475鈥?81CrossRef PubMed
    68.Ngueguim FT, Khan MP, Donfack JH, Tewari D, Dimo T, Kamtchouing P et al (2013) Ethanol extract of Peperomia pellucida (Piperaceae) promotes fracture healing by an anabolic effect on osteoblasts. J Ethnopharmacol 148:62鈥?8CrossRef PubMed
  • 作者单位:Ali Aydin (1)
    Zekai Halici (2)
    Erol Akpinar (2)
    A. Murat Aksakal (3)
    Murat Saritemur (4)
    Muhammed Yayla (2)
    C. Semih Kunak (5)
    Elif Cadirci (6)
    H. Tarik Atmaca (7)
    S. Sena Karcioglu (2)

    1. Department of Orthopedics and Traumatology, Ataturk University Faculty of Medicine, 25240, Erzurum, Turkey
    2. Department of Pharmacology, Ataturk University Faculty of Medicine, 25240, Erzurum, Turkey
    3. Department of Orthopedics and Traumathology, Sevket Yilmaz Education and Research Hospital, Bursa, Turkey, 16230
    4. Department of Emergency Medicine, Ataturk University Faculty of Pharmacy, 25240, Erzurum, Turkey
    5. Department of Pharmacology, Ordu University Faculty of Medicine, 52240, Ordu, Turkey
    6. Department of Pharmacology, Ataturk University Faculty of Pharmacy, 25240, Erzurum, Turkey
    7. Department of Pathology, K谋r谋kkale University Faculty of Veterinary, 71240, K谋r谋kkale, Turkey
  • 刊物类别:Medicine
  • 刊物主题:Medicine & Public Health
    Metabolic Diseases
    Orthopedics
    Internal Medicine
  • 出版者:Springer Japan
  • ISSN:1435-5604
文摘
The purpose of this study was to examine the effects bosentan (which is a strong vasoconstrictor) on bone fracture pathophysiology, and investigate the roles of the nonselective endothelin 1 receptor blocker bosentan on the bone fractures formed in rats through radiographic, histopathologic, and immunohistochemical methods. The rats were divided into three groups (six rats in each group): a femoral fracture control group, a femoral fracture plus bosentan at 50 mg/kg group, and a femoral fracture plus bosentan at 100 mg/kg group. The femoral fracture model was established by transversely cutting the femur at the midsection. After manual reduction, the fractured femur was fixed with intramedullary Kirschner wires. The radiographic healing scores of the bosentan 100 and 50 mg/kg groups were significantly better that those of the fracture control group. The fracture callus percent of new bone in the bosentan 100 mg/kg group was significantly greater than that in the control group. Also, semiquantitative analysis showed higher positive vascular endothelial growth factor and osteocalcin staining and lower positive endothelin receptor type A staining in the treatment groups than in the control group. Bosentan treatment also decreased tissue endothelin 1 expression relative to that in the fracture control group. As a result of our study, the protective effect of bosentan was shown in experimental femoral fracture healing in rats by radiographic, histopathologic, and molecular analyses. Keywords Bosentan Endothelin 1 Bone fracture Rat Femur

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700